MARKET

VCYT

VCYT

Veracyte
NASDAQ
38.90
+0.65
+1.70%
After Hours: 38.90 0 0.00% 16:50 05/14 EDT
OPEN
38.88
PREV CLOSE
38.25
HIGH
39.66
LOW
38.05
VOLUME
902.96K
TURNOVER
--
52 WEEK HIGH
50.71
52 WEEK LOW
22.61
MARKET CAP
3.10B
P/E (TTM)
36.03
1D
5D
1M
3M
1Y
5Y
1D
Tracking Cathie Wood's ARK Invest 13F Portfolio - Q1 2026 Update
Seeking Alpha · 1d ago
Veracyte (VCYT) Gets a Sell from Morgan Stanley
TipRanks · 2d ago
Cathie Wood's weekly recap: buys TEM, WGS, and CRWV; sells AMD and RKLB
Seeking Alpha · 3d ago
Weekly Report: what happened at VCYT last week (0504-0508)?
Weekly Report · 3d ago
Veracyte SVP, General Counsel Annie McGuire disposes 10,204 shares for $398,130.10
PUBT · 6d ago
Tempus AI: My Pick For An Oncoming Boom In Demand For Data-Driven Precision Medicine
Seeking Alpha · 6d ago
Veracyte price target raised to $42 from $40 at Canaccord
TipRanks · 05/07 06:56
Veracyte price target raised to $52 from $48 at UBS
TipRanks · 05/07 03:55
More
About VCYT
Veracyte, Inc. is a global diagnostics company. It enables clinicians with insights they need to guide and assure patients. The Company offers tests for thyroid cancer (Afirma), prostate cancer (Decipher Prostate), breast cancer (Prosigna), interstitial lung diseases (Envisia), and bladder cancer (Decipher Bladder). Its Percepta Nasal Swab test is being run in its Clinical Laboratory Improvement Amendments (CLIA) lab in support of clinical studies and its tests for kidney cancer and lymphoma are in development, the latter as a companion diagnostic. Its products consist of the Prosigna breast cancer assay, the nCounter Analysis System, related diagnostic kits, and services. In the United States, it offers laboratory developed tests (LDTs), through its CLIA laboratories in South San Francisco and San Diego, California, supported by its cytopathology know-how in Austin, Texas. The Company also offers whole-genome MRD platform that enable it in early cancer diagnosis and risk assessment.

Webull offers Veracyte Inc stock information, including NASDAQ: VCYT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VCYT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading VCYT stock methods without spending real money on the virtual paper trading platform.